Christopher R. Aker
2019
In 2019, Christopher R. Aker earned a total compensation of $787.9K as SVP & General Counsel at Regulus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $275,500 |
|---|---|
| Option Awards | $188,913 |
| Salary | $290,000 |
| Stock Awards | $23,696 |
| Other | $9,798 |
| Total | $787,907 |
Aker received $290K in salary, accounting for 37% of the total pay in 2019.
Aker also received $275.5K in non-equity incentive plan, $188.9K in option awards, $23.7K in stock awards and $9.8K in other compensation.
Rankings
In 2019, Christopher R. Aker's compensation ranked 10,280th out of 13,971 executives tracked by ExecPay. In other words, Aker earned more than 26.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,280 out of 13,971 | 26th |
Division Manufacturing | 4,160 out of 5,701 | 27th |
Major group Chemicals And Allied Products | 1,596 out of 2,200 | 28th |
Industry group Drugs | 1,367 out of 1,886 | 28th |
Industry Pharmaceutical Preparations | 1,017 out of 1,398 | 27th |
Source: SEC filing on April 29, 2020.
Aker's colleagues
We found three more compensation records of executives who worked with Christopher R. Aker at Regulus Therapeutics in 2019.